These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26036856)

  • 21. Ethical issues raised by whole genome sequencing.
    Pinxten W; Howard HC
    Best Pract Res Clin Gastroenterol; 2014 Apr; 28(2):269-79. PubMed ID: 24810188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing.
    Yu JH; Crouch J; Jamal SM; Bamshad MJ; Tabor HK
    Am J Med Genet A; 2014 Sep; 164A(9):2153-60. PubMed ID: 24845082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unsolicited genomic findings in daily clinical practice].
    Wouters RHP; Bijlsma RM; Voest EE; Bredenoord AL
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent.
    Levenseller BL; Soucier DJ; Miller VA; Harris D; Conway L; Bernhardt BA
    J Genet Couns; 2014 Aug; 23(4):552-65. PubMed ID: 23846343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tension between data sharing and the protection of privacy in genomics research.
    Kaye J
    Annu Rev Genomics Hum Genet; 2012; 13():415-31. PubMed ID: 22404490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical sequencing: is WGS the better WES?
    Meienberg J; Bruggmann R; Oexle K; Matyas G
    Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
    Chou J; Ohsumi TK; Geha RS
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To share or not to share: a randomized trial of consent for data sharing in genome research.
    McGuire AL; Oliver JM; Slashinski MJ; Graves JL; Wang T; Kelly PA; Fisher W; Lau CC; Goss J; Okcu M; Treadwell-Deering D; Goldman AM; Noebels JL; Hilsenbeck SG
    Genet Med; 2011 Nov; 13(11):948-55. PubMed ID: 21785360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient privacy in the genomic era.
    Raisaro JL; Ayday E; Hubaux JP
    Praxis (Bern 1994); 2014 May; 103(10):579-86. PubMed ID: 24800770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personal genomic screening: How best to facilitate preparedness of future clients.
    Fleming J; Terrill B; Dziadek M; Kirk EP; Roscioli T; Barlow-Stewart K
    Eur J Med Genet; 2019 May; 62(5):397-404. PubMed ID: 31085343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium.
    Zoltick ES; Linderman MD; McGinniss MA; Ramos E; Ball MP; Church GM; Leonard DGB; Pereira S; McGuire AL; Caskey CT; Sanderson SC; Schadt EE; Nielsen DE; Crawford SD; Green RC;
    Genome Med; 2019 Feb; 11(1):10. PubMed ID: 30808425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient perspectives on whole-genome sequencing for undiagnosed diseases.
    Boeldt DL; Cheung C; Ariniello L; Darst BF; Topol S; Schork NJ; Philis-Tsimikas A; Torkamani A; Fortmann AL; Bloss CS
    Per Med; 2017 Jan; 14(1):17-25. PubMed ID: 29749824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data.
    Ferrarini A; Xumerle L; Griggio F; Garonzi M; Cantaloni C; Centomo C; Vargas SM; Descombes P; Marquis J; Collino S; Franceschi C; Garagnani P; Salisbury BA; Harvey JM; Delledonne M
    PLoS One; 2015; 10(7):e0132180. PubMed ID: 26147798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public attitudes in Japan toward participation in whole genome sequencing studies.
    Okita T; Ohashi N; Kabata D; Shintani A; Kato K
    Hum Genomics; 2018 Apr; 12(1):21. PubMed ID: 29653595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferences for the provision of whole genome sequencing services among young adults.
    Wade CH; Elliott KR
    PLoS One; 2017; 12(3):e0174131. PubMed ID: 28334023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-guided management of exome and whole-genome sequencing results: changing the results return model.
    Yu JH; Jamal SM; Tabor HK; Bamshad MJ
    Genet Med; 2013 Sep; 15(9):684-90. PubMed ID: 23619276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
    Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
    Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Points to consider for informed consent for genome/exome sequencing.
    ACMG Board of Directors
    Genet Med; 2013 Sep; 15(9):748-9. PubMed ID: 23970068
    [No Abstract]   [Full Text] [Related]  

  • 40. Opportunities and Challenges in Interpreting and Sharing Personal Genomes.
    Rubin IR; Glusman G
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31450660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.